Market Tracker

04/28 4:09am ET

Cytokinetics Inc (NASDAQ:CYTK)

17.00
Delayed Data
As of Apr 27
 +0.10 / +0.59%
Today’s Change
7.18
Today|||52-Week Range
17.20
+39.92%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close16.90
Today’s open16.95
Day’s range16.45 - 17.20
Volume1,044,631
Average volume (3 months)482,676
Market cap$730.8M
Dividend yield--
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-730.77%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratio43.6
Price/Sales4.86
Price/Book7.28

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.20-1.65%
OMEROmeros Corp+0.18+1.10%
ACRSAclaris Therapeutics...-0.05-0.17%
MGNXMacroGenics Inc+0.07+0.32%
Data as of 04/27/2017

Financials

Last reporting dateApril 28, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts